Non-Myeloid Malignancies
Also known as: Non-myeloid malignancy / Nonmyeloid malignancies
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB18704 | Efbemalenograstim alfa | A granulocyte-colony stimulating factor used to treat prevent chemotherapy-induced neutropenia. |
| DB15001 | Eflapegrastim | A form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy. |
| DB00016 | Erythropoietin | A recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. |
| DB00099 | Filgrastim | A form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy. |
| DB00038 | Oprelvekin | A form of recombinant interleukin-11 used to stimulate production of megakaryocytes and platelets in patients with or at risk of thrombocytopenia after chemotherapy. |
| DB00019 | Pegfilgrastim | A recombinant human granulocyte colony stimulating factor used to stimulate the production of neutrophils and prevent febrile neutropenia or infections after myelosuppressive chemotherapy. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00012 | Darbepoetin alfa | 2 | Completed | 5 |
| DB00012 | Darbepoetin alfa | 2 | Terminated | 1 |
| DB00893 | Iron Dextran | 2 | Completed | 1 |
| DB00012 | Darbepoetin alfa | 3 | Completed | 3 |
| DB01592 | Iron | 3 | Completed | 1 |
| DB12208 | Iron isomaltoside 1000 | 3 | Completed | 1 |
| DB00019 | Pegfilgrastim | Not Available | Unknown Status | 1 |